Your browser doesn't support javascript.
loading
Novel Potential Targets for Function-Promoting Therapies: Orphan Nuclear Receptors, Anti-inflammatory Drugs, Troponin Activators, Mas Receptor Agonists, and Urolithin A.
Dioh, Waly; Narkar, Vihang; Singh, Anurag; Malik, Fady; Ferrucci, Luigi; Tourette, Cendrine; Mariani, Jean; van Maanen, Rob; Fielding, Roger A.
Affiliation
  • Dioh W; Biophytis, UMPC-BC9, Paris, France.
  • Narkar V; Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center (UTHealth), Houston, Texas, USA.
  • Singh A; Amazentis SA, Ecublens, Switzerland.
  • Malik F; Cytokinetics, Inc., San Francisco, California, USA.
  • Ferrucci L; National Institute on Aging, National Institutes of Health, U.S. Department of Health and Human Services, Baltimore, Maryland, USA.
  • Tourette C; Biophytis, UMPC-BC9, Paris, France.
  • Mariani J; Biophytis, UMPC-BC9, Paris, France.
  • van Maanen R; Sorbonne Université, CNRS-Institute de Biologie Paris Seine (UMR B2A), Paris, France.
  • Fielding RA; Biophytis, UMPC-BC9, Paris, France.
J Gerontol A Biol Sci Med Sci ; 78(Suppl 1): 44-52, 2023 06 16.
Article in En | MEDLINE | ID: mdl-37325960

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orphan Nuclear Receptors / Anti-Inflammatory Agents Language: En Journal: J Gerontol A Biol Sci Med Sci Journal subject: GERIATRIA Year: 2023 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orphan Nuclear Receptors / Anti-Inflammatory Agents Language: En Journal: J Gerontol A Biol Sci Med Sci Journal subject: GERIATRIA Year: 2023 Document type: Article Affiliation country: Francia